Acquisitions and Grants Support Services

Added: Jun 16, 2017 5:24 pm

The purpose of Amendment 002 is to provide remaining Attachment J_Vendor Questions and Responses, and update the Solicitation 17-223-SOL-00038. Please see the attachments to Amendment 002. 


Proposals are due no later than 11:00 PM Eastern time (ET) on Tuesday, 27 June 2017.

Added: Jun 13, 2017 1:53 pm The purpose of Amendment Number 001 is to provide Attachment J_Vendor Questions and Responses, and updates to Attachment A_Statement of Work, Attachment B_Acquisitions and Grants Support Services Labor Categories and Descriptions, Attachment D_Pricing Worksheets, and the Solicitation 17-223-SOL-00038. Please see the revised attachments.


The proposal due date is extended to June 22, 2017, 11:00 PM ET.

Added: May 17, 2017 2:56 pm The Food and Drug Administration's (FDA's) mission is "Protecting consumers and enhancing public health by maximizing compliance of FDA regulated products and minimizing risk associated with those products." And our vision is: "All food is safe; all medical products are safe and effective; and the public health is advanced and protected."

The Office of Acquisitions and Grants Support Services primarily serves the Agency by initiating contracts, grants and cooperative agreements, inter-agency agreements (IAAs), and oversees the FDA's Government Purchase Card Program. Due to the high workload associated with completing acquisition actions to include requirement development, award documentation, and conducting contract close-out actions; it has become necessary for OAGS to seek external acquisition support services to assist with completing the multitude of work activities.

OAGS completes several thousand-acquisition actions on an annual basis. These actions include contracts, grants and cooperative agreements, and IAAs.

The primary objectives of this contract include the following:

• Provide acquisition and grant support services to OAGS as related to the full spectrum of acquisition activities, in accordance with the IDIQ Contract and Individual Task Orders (ITOs).
• Ensure contracts, grants and cooperative agreements, and inter-agency agreements are awarded per designated service level agreement (SLA) and in accordance with requisite statutes.
• Provide program and task order management for the Acquisitions and Grants Support Services IDIQ requirements during the prescribed period of performance.

It is the FDA's intent to award one (1) indefinite delivery-indefinite quantity (IDIQ) contract, with an ordering period of five (5) years and a ceiling of $19,000,000.00.

NOTICE OF COMBINED SYNOPSIS/SOLICITATION

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This is a solicitation for commercial items in accordance with the procedures of FAR Part 12 - Acquisition of Commercial Items and FAR Part 15 - Contracting by Negotiation.

This requirement is set aside for 8(a) concerns.

LIST OF ATTACHMENTS
Solicitation 17-223-SOL-00038
Attachment A - Statement of Work (SOW)
Attachment B - Acquisitions and Grants Support Services Labor Categories and Descriptions
Attachment C - Past Performance Questionnaire
Attachment D - OAGS IDIQ Pricing Worksheets
Attachment E - FAR Provision 52.212-3
Attachment F - FAR Clause 52.212-5
Attachment G - FDA 1335 Personnel Security Clearance Requirements
Attachment H - Commitment to Protect Non-Public Information (NPI) Employee Agreement, From
FDA 3398
Attachment I - Sample Commitment Letter
Attachment J - Vendor Question Format

All questions must be submitted by 11:00 PM Eastern time (ET) on 26 May 2017. See Question Submittal Instructions.